Skip to main content
Clinical Trials/JPRN-jRCTs032190053
JPRN-jRCTs032190053
Recruiting
Phase 1

Evaluation of safety of knee extension and flexion training using the wearable motion support robot (single joint type of Hybrid Assistive Limb (HAL-SJ)) for patients with anterior cruciate ligament injury - Evaluation of safety of knee extension and flexion training using the wearable motion support robot (single joint type of Hybrid Assistive Limb (HAL-SJ)) for patients with anterior cruciate ligament injury

Yamazaki Masashi0 sites30 target enrollmentJuly 8, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Yamazaki Masashi
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamazaki Masashi

Eligibility Criteria

Inclusion Criteria

  • All patients with ACL\-injured patients and ACL reconstructive surgery who were consulted at our hospital orthopedic surgery
  • 1\.Primary ACL injured patients
  • 2\.Patients with harvested are semitendinosus tendon alone or both semitendinosus and gracilis tendons
  • 3\.Be observable throughout the entire research period
  • 4\.Patients who weigh 40\-100 kg and height 150\-190 cm and are able to wear HAL
  • 5\.Patient who can accept document consent

Exclusion Criteria

  • Patients who conflict with one of the following criteria are excluded and are not subject to this clinical study
  • 1\.Patients with multiple knee ligament injuries
  • 2\.Bilateral simultaneous surgery patient
  • 3\.Patients who are considered difficult to wear and train HAL due to underlying disease or perioperative complications
  • 4\.Patients with bleeding tendencies or complications that are problematic for training
  • 5\.Patients who can not affix HAL biological electrode due to skin diseases or other things
  • 6\.Patients who had participated in other research within 12 weeks of starting this clinical study
  • 7\.Patients who judged that participation in this study is inappropriate by clinical trial responsible doctor or clinical trial sharing doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials